Dr. Kirk Taylor to Speak About Ethics in Medicine and Genetic Laboratory Testing

Dr. Kirk Taylor to Speak About Ethics in Medicine and Genetic Laboratory Testing


Margo Schafer Pelak
Prescient Medicine Media Relations

Dr. Kirk Taylor to Speak About Ethics in Medicine and Genetic Laboratory Testing

HUMMELSTOWN, Pa., Mar. 9, 2017 – Kirk Taylor, M.D., Chief Medical Officer at Prescient Medicine, will speak about genetic laboratory testing to Behavioral Health professionals at the “Ethics in Behavioral Healthcare” conference in Pittsburgh, Pa. at 11 a.m. on March 14 at the LeMont Restaurant, 1113 Grandview, Pittsburgh.  

With increased scrutiny of drug testing payment mechanisms, and with an opioid epidemic taking center stage in the U.S., laboratory testing in Behavioral Health has become a hot topic. Dr. Taylor will discuss ethical concerns for medication monitoring in addiction patients as well as the new field of genetic testing and how it may apply to addiction medicine.

“Behavioral Health providers often struggle with making informed care decisions while not overtesting. There is a balance that must be achieved,” said Dr. Taylor.

A new category of medicine has emerged called “Precision Medicine” – which matches a patient’s unique genetic profile to their medical needs. As a laboratory leader in this emerging category, Prescient Medicine offers advanced genetic testing services that may help reduce the risk of adverse drug reactions, overdose and addiction.

# # #

About Kirk Taylor

Kirk Taylor, M.D., is Chief Medical Officer at Prescient Medicine. Prior to joining Prescient Medicine, he spent 12 years in clinical practice and 20 years as a pharmaceutical executive.  He has held executive roles at Pfizer, Biogen, Actelion and Sanofi Genzyme. He earned a B.A. from Harvard University and an M.D. from State University of New York. He completed a neurology residency at the Albert Einstein College of Medicine and a postdoc in neuropathic pain and headache at University of California San Francisco. He has taken Executive MBA courses at INSEAD and Harvard Business School.

About Prescient Medicine

Prescient Medicine is delivering the tools that define the precision healthcare movement—the future of medicine. We believe that with deeper predictive insights, tomorrow's researchers and caregivers can make better decisions, leading to the best possible patient outcomes. Through our expertise in pharmacology, chemistry, in vitro diagnostics (IVD), pathology, pharmacogenomics, and toxicology, we’ve created powerful tests and analytics that deliver the advanced test results and methodologies that help physicians and our partners make the right choice at the right time. Prescient has locations in Pennsylvania and Missouri and will open a Florida location later this year. Visit us at